Glaxosmithkline Pharmaceuticals’ advanced 1.45% to Rs 2667.95 after the company’s standalone net profit jumped 15.38% to Rs 248.69 crore on 4.9% increase in revenue from operations to Rs 1,000.05 crore in Q2 FY25 over Q2 FY24.
| Subscribe To Our Free Newsletter |
